An Arizona surgeon and advocate for making more pharmaceutical products available OTC isn’t sure the Food and Drug Administration is ready to approve the change for a drug he’s singled out as a prime candidate, daily oral contraceptives.
The FDA’s history with emergency contraceptives and with opioid overdose antidote naloxone doesn’t assure Jeffrey Singer, president emeritus and founder...







